SB

Someshwar Balaji Khodave

Active Director Designated Partner DIN 11526275
DIN 11526275 First appointment Feb 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Someshwar Balaji Khodave

Data last updated:

Someshwar Balaji Khodave is a Designated Partner at G-Lx Med Plus Mart Llp (since 2026).

DIN 11526275
Primary Designation Designated Partner
First Appointment 05 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner05 Feb 20262026Active

Board colleagues of Someshwar Balaji Khodave

NameDINCompanyDesignation
Mohan Balaji Khodve11526274G-Lx Med Plus Mart LlpDesignated Partner

Directorship timeline

Open interactive timeline →
G-Lx Med Plus Mart Llp
Premium access

Shareholding and investment profile for Someshwar Balaji Khodave

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Someshwar Balaji Khodave

Someshwar Balaji Khodave currently holds 1 directorship: G-Lx Med Plus Mart Llp (Designated Partner, since 05 Feb 2026).

Someshwar Balaji Khodave was first appointed on 05 Feb 2026 as Designated Partner at G-Lx Med Plus Mart Llp.

The current boards of Someshwar Balaji Khodave's companies include Mohan Balaji Khodve (G-Lx Med Plus Mart Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available